Christopher Ogden - Chief Financial Officer at CytomX Therapeutics, Inc.

Issuer-level insider activity

Role
Chief Financial Officer
Issuer ticker
CTMX on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

Past-year transaction volume for Christopher Ogden in CytomX Therapeutics, Inc.

Buys

Open market
Shares
Avg price
Total value

Sells

Open market
Shares
-20,947
Avg price
$6.16
Total value
-$129,065

Net

Past year
Shares
-20,947
Share %
-100%
Total value
-$129,065

Reported holdings for Christopher Ogden in CytomX Therapeutics, Inc.

Form 4 holding Chief Financial Officer

CytomX Therapeutics, Inc.

Security class
Performance Stock Units (PSUs)
Shares / value
39,150
Estimated value
$0
Report date
26 Sep 2025
Price
$1.23
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Financial Officer

CytomX Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
325,000
Estimated value
Report date
02 Feb 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Christopher Ogden in CytomX Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .